Pet Metabolic Health Market
PUBLISHED: 2026 ID: SMRC41446
SHARE
SHARE

Pet Metabolic Health Market

Pet Metabolic Health Market Forecasts to 2034 - Global Analysis By Product Category (Endocrine and Metabolic Therapeutics, Metabolic Health Supplements, Clinical Diagnostic and Monitoring Tools, Veterinary Nutrition Adjuncts), Health Condition, Pet Type, Care Setting, Diagnostic and Monitoring Tool, Professional Channel, and By Geography

4.3 (86 reviews)
4.3 (86 reviews)
Published: 2026 ID: SMRC41446

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...
According to Stratistics MRC, the Global Pet Metabolic Health Market is accounted for $1.2 billion in 2026 and is expected to reach $2.2 billion by 2034 growing at a CAGR of 7.9% during the forecast period. The market covers diagnostic, therapeutic and nutritional solutions for metabolic and endocrine disorders beyond diabetes, including endocrine medicines, laboratory panels, and metabolic supplements. It is used to support detection and ongoing management of thyroid, lipid and related metabolic conditions. Growth reflects greater diagnostic access and demand for integrated chronic-disease management. Further uptake will be shaped by technology readiness, customer confidence, pricing and the breadth of service networks.

Market Dynamics:


Driver:


Increasing recognition of chronic metabolic conditions in companion animals


Demand in pet metabolic health is supported by the need to identify and manage disorders such as diabetes mellitus, thyroid dysfunction and lipid or glucose abnormalities in companion animals. Veterinary clinics use blood and urine testing to assess metabolic status, while treatment plans may combine medication, therapeutic nutrition and repeat monitoring. Pet owners increasingly seek ongoing management when symptoms such as weight change, altered thirst, appetite shifts or lethargy persist. Diagnostic products, laboratory services and condition-specific diets therefore serve connected parts of the care pathway. Chronic disease management creates recurring demand for monitoring and treatment support.
Restraint:


Diagnostic gaps, treatment costs and long-term owner compliance


Metabolic disorders can be difficult to identify because signs such as weight fluctuation, increased thirst and reduced activity overlap with other illnesses or normal ageing. Diagnosis may require laboratory testing and repeat measurements, adding cost and requiring access to veterinary services. Treatment can involve daily medication, insulin administration, controlled feeding and regular monitoring, which places a continuing burden on owners. Cats and dogs may also respond differently to treatment, requiring dose or diet adjustments. Inconsistent follow-up can compromise disease control, while limited access to veterinary laboratories restricts timely diagnosis in some locations.
Opportunity:


Integrated testing, therapeutic nutrition and preventive veterinary care


An important opportunity lies in linking diagnostic testing with therapeutic nutrition and longitudinal veterinary monitoring. Point-of-care assays can help clinics assess glucose or related metabolic indicators during consultations, while laboratory panels support more detailed evaluation when required. Condition-specific diets can complement treatment for animals with diabetes, obesity-related metabolic dysfunction or lipid abnormalities. Digital reminders and connected monitoring tools may help owners maintain medication, feeding and testing schedules. Suppliers that coordinate veterinary clinics, diagnostic laboratories and pet nutrition providers can offer a more continuous management pathway than standalone products.
Threat:


Regulatory scrutiny and competition from established veterinary therapies


Alternative care approaches can compete with dedicated metabolic-health products when owners rely on general wellness foods, home monitoring or delayed veterinary visits instead of structured diagnosis and treatment. Inaccurate home test interpretation may create false reassurance or unnecessary concern, while unsubstantiated supplements can divert spending from clinically appropriate care. Diagnostic providers also face competition from established veterinary laboratories and clinic-owned testing systems. Changes in testing protocols or clinical recommendations can make some products less relevant. Companies must maintain analytical reliability, clear interpretation guidance and compatibility with veterinary workflows to sustain professional confidence.
Covid-19 Impact:


The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.

The Endocrine and Metabolic Therapeutics segment is expected to be the largest during the forecast period


The Endocrine and Metabolic Therapeutics segment is expected to account for a leading share of the pet metabolic health market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal product category applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.

The Metabolic Comorbidities segment is expected to have the highest CAGR during the forecast period


The Metabolic Comorbidities segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.


Region with largest share:


North America is expected to account for a leading share of the pet metabolic health market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.

Region with highest CAGR:


Asia Pacific is expected to exhibit strong growth in the pet metabolic health market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.

Key players in the market


Some of the key players in the Global Pet Metabolic Health Market include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Boehringer Ingelheim Animal Health, Dechra Pharmaceuticals PLC, Ceva Santé Animale, Virbac, Vetoquinol, IDEXX Laboratories, Inc., Antech Diagnostics, Hill’s Pet Nutrition, Royal Canin, Nestlé Purina PetCare, Nutramax Laboratories, PetMed Express, Inc..

Key Developments:


In October 2026, Fera Pets introduced a daily soft chew formulated to support lean muscle, metabolism and body condition in dogs.

In September 2026, American Animal Hospital Association released updated canine diabetes-management guidelines covering diagnosis, insulin treatment, continuous glucose monitoring, dietary management and follow-up care.

In July 2026, Royal Canin (Mars Petcare) launched its first fresh, fully cooked veterinary diet portfolio for dogs, addressing selected gastrointestinal needs, food sensitivities and reduced appetite through veterinarian-exclusive nutrition.

Product Categories Covered:

• Endocrine and Metabolic Therapeutics
• Metabolic Health Supplements
• Clinical Diagnostic and Monitoring Tools
• Veterinary Nutrition Adjuncts

Health Conditions Covered:

• Thyroid and Endocrine Disorders
• Lipid and Glucose Metabolism
• Hepatic and Pancreatic Conditions
• Metabolic Comorbidities

Pet Types Covered:

• Dogs
• Cats
• Other Companion Animals

Care Settings Covered:

• Veterinary Hospitals
• Specialty Internal Medicine Clinics
• Online Veterinary Pharmacies
• Home Monitoring Programs

Diagnostic and Monitoring Tools Covered:

• Blood Chemistry and Endocrine Panels
• Continuous and Spot Glucose Monitoring
• Urine and Ketone Testing
• Longitudinal Metabolic Biomarkers

Professional Channels Covered:

• General Veterinary Practices
• Specialty Endocrinology Providers
• Veterinary Diagnostic Laboratories
• Direct Veterinary E-Pharmacy

Regions Covered:

• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Pet Metabolic Health Market, By Product Category

5.1 Endocrine and Metabolic Therapeutics
5.2 Metabolic Health Supplements
5.3 Clinical Diagnostic and Monitoring Tools
5.4 Veterinary Nutrition Adjuncts

6 Global Pet Metabolic Health Market, By Health Condition

6.1 Thyroid and Endocrine Disorders
6.2 Lipid and Glucose Metabolism
6.3 Hepatic and Pancreatic Conditions
6.4 Metabolic Comorbidities

7 Global Pet Metabolic Health Market, By Pet Type

7.1 Dogs
7.2 Cats
7.3 Other Companion Animals

8 Global Pet Metabolic Health Market, By Care Setting

8.1 Veterinary Hospitals
8.2 Specialty Internal Medicine Clinics
8.3 Online Veterinary Pharmacies
8.4 Home Monitoring Programs

9 Global Pet Metabolic Health Market, By Diagnostic and Monitoring Tool

9.1 Blood Chemistry and Endocrine Panels
9.2 Continuous and Spot Glucose Monitoring
9.3 Urine and Ketone Testing
9.4 Longitudinal Metabolic Biomarkers

10 Global Pet Metabolic Health Market, By Professional Channel

10.1 General Veterinary Practices
10.2 Specialty Endocrinology Providers
10.3 Veterinary Diagnostic Laboratories
10.4 Direct Veterinary E-Pharmacy

11 Global Pet Metabolic Health Market, By Geography

11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles

14.1 Zoetis Inc.
14.2 Elanco Animal Health
14.3 Merck Animal Health
14.4 Boehringer Ingelheim Animal Health
14.5 Dechra Pharmaceuticals PLC
14.6 Ceva Santé Animale
14.7 Virbac
14.8 Vetoquinol
14.9 IDEXX Laboratories, Inc.
14.10 Antech Diagnostics
14.11 Hill’s Pet Nutrition
14.12 Royal Canin
14.13 Nestlé Purina PetCare
14.14 Nutramax Laboratories
14.15 PetMed Express, Inc.

List of Tables

1 Global Pet Metabolic Health Market Outlook, By Region (2023–2034) ($MN)
2 Global Pet Metabolic Health Market Outlook, By Product Category (2023–2034) ($MN)
3 Global Pet Metabolic Health Market Outlook, By Endocrine and Metabolic Therapeutics (2023–2034) ($MN)
4 Global Pet Metabolic Health Market Outlook, By Metabolic Health Supplements (2023–2034) ($MN)
5 Global Pet Metabolic Health Market Outlook, By Clinical Diagnostic and Monitoring Tools (2023–2034) ($MN)
6 Global Pet Metabolic Health Market Outlook, By Veterinary Nutrition Adjuncts (2023–2034) ($MN)
7 Global Pet Metabolic Health Market Outlook, By Health Condition (2023–2034) ($MN)
8 Global Pet Metabolic Health Market Outlook, By Thyroid and Endocrine Disorders (2023–2034) ($MN)
9 Global Pet Metabolic Health Market Outlook, By Lipid and Glucose Metabolism (2023–2034) ($MN)
10 Global Pet Metabolic Health Market Outlook, By Hepatic and Pancreatic Conditions (2023–2034) ($MN)
11 Global Pet Metabolic Health Market Outlook, By Metabolic Comorbidities (2023–2034) ($MN)
12 Global Pet Metabolic Health Market Outlook, By Pet Type (2023–2034) ($MN)
13 Global Pet Metabolic Health Market Outlook, By Dogs (2023–2034) ($MN)
14 Global Pet Metabolic Health Market Outlook, By Cats (2023–2034) ($MN)
15 Global Pet Metabolic Health Market Outlook, By Other Companion Animals (2023–2034) ($MN)
16 Global Pet Metabolic Health Market Outlook, By Care Setting (2023–2034) ($MN)
17 Global Pet Metabolic Health Market Outlook, By Veterinary Hospitals (2023–2034) ($MN)
18 Global Pet Metabolic Health Market Outlook, By Specialty Internal Medicine Clinics (2023–2034) ($MN)
19 Global Pet Metabolic Health Market Outlook, By Online Veterinary Pharmacies (2023–2034) ($MN)
20 Global Pet Metabolic Health Market Outlook, By Home Monitoring Programs (2023–2034) ($MN)
21 Global Pet Metabolic Health Market Outlook, By Diagnostic and Monitoring Tool (2023–2034) ($MN)
22 Global Pet Metabolic Health Market Outlook, By Blood Chemistry and Endocrine Panels (2023–2034) ($MN)
23 Global Pet Metabolic Health Market Outlook, By Continuous and Spot Glucose Monitoring (2023–2034) ($MN)
24 Global Pet Metabolic Health Market Outlook, By Urine and Ketone Testing (2023–2034) ($MN)
25 Global Pet Metabolic Health Market Outlook, By Longitudinal Metabolic Biomarkers (2023–2034) ($MN)
26 Global Pet Metabolic Health Market Outlook, By Professional Channel (2023–2034) ($MN)
27 Global Pet Metabolic Health Market Outlook, By General Veterinary Practices (2023–2034) ($MN)
28 Global Pet Metabolic Health Market Outlook, By Specialty Endocrinology Providers (2023–2034) ($MN)
29 Global Pet Metabolic Health Market Outlook, By Veterinary Diagnostic Laboratories (2023–2034) ($MN)
30 Global Pet Metabolic Health Market Outlook, By Direct Veterinary E-Pharmacy (2023–2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials